CompaniesPharmaterials

Pharmaterials

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

299

By Phase

NA: 1PHASE2: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT01265524
Hover over trial bars to see details

Recent Trials

NCT03673995Lead Sponsor
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
NACompleted
186 participants
Started: May 2, 2017 · Completed: Oct 30, 2018
NCT01265524Collaborator
Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
PHASE2Completed
113 participants
Started: Apr 30, 2011
Related Companies
Quotient Sciences
acquired